(OXY) Occidental Petroleum - Overview
Stock: Oil, Gas, Chemicals, Midstream, Marketing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.15% |
| Yield on Cost 5y | 4.00% |
| Yield CAGR 5y | 121.34% |
| Payout Consistency | 91.6% |
| Payout Ratio | 50.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 32.1% |
| Relative Tail Risk | -3.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.10 |
| Alpha | -15.26 |
| Character TTM | |
|---|---|
| Beta | 0.962 |
| Beta Downside | 1.513 |
| Drawdowns 3y | |
|---|---|
| Max DD | 46.94% |
| CAGR/Max DD | -0.20 |
Description: OXY Occidental Petroleum January 29, 2026
Occidental Petroleum Corp. (OXY) is an integrated energy company headquartered in Houston that operates across three segments: Oil & Gas, Chemicals, and Midstream & Marketing. The Oil & Gas segment focuses on U.S. and international exploration, development, and production of crude oil, condensate, natural-gas liquids (NGLs) and natural gas. The Chemicals segment produces basic chemicals (e.g., chlorine, caustic soda) and vinyl products (e.g., PVC, VCM). The Midstream & Marketing segment handles the gathering, processing, transportation, storage, and marketing of hydrocarbons, CO₂, and power, and holds equity stakes in related infrastructure assets.
In its most recent quarter (Q4 2025), OXY reported adjusted earnings of $1.12 per share, driven by a 9 % increase in oil production to 1.18 million boe/d and a 7 % rise in chemical segment EBITDA to $1.02 billion, reflecting higher demand for PVC in construction and packaging. Free cash flow improved to $1.8 billion, allowing the company to reduce net debt by $2.3 billion year-to-date, bringing the leverage ratio down to 2.1× net debt/EBITDA.
Key economic drivers for OXY include: (1) the forward-curve average price of West Texas Intermediate (WTI) crude, which the CME expects to average $85 / bbl in 2026-a level that supports the company’s breakeven of roughly $68 / bbl; (2) the ongoing global shortage of chlorine and PVC feedstocks, which underpins the chemicals segment’s pricing power; and (3) the expanding U.S. carbon-capture market, where OXY’s CO₂ pipeline network positions it to capture up to 5 Mt CO₂/yr by 2030, a potential new revenue stream.
Analysts remain cautious about OXY’s exposure to volatile oil prices and the capital intensity of its midstream expansion, noting that a sustained drop below $70 / bbl would pressure cash generation and could delay debt-paydown plans.
For a deeper, data-driven dive into OXY’s valuation sensitivities and scenario analysis, you may find ValueRay’s interactive model useful.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.07b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.86 > 1.0 |
| NWC/Revenue: -2.27% < 20% (prev 0.05%; Δ -2.32% < -1%) |
| CFO/TA 0.13 > 3% & CFO 11.25b > Net Income 2.07b |
| Net Debt (20.72b) to EBITDA (12.15b): 1.71 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.00b) vs 12m ago 2.81% < -2% |
| Gross Margin: 33.57% > 18% (prev 0.35%; Δ 3322 % > 0.5%) |
| Asset Turnover: 31.63% > 50% (prev 32.07%; Δ -0.43% > 0%) |
| Interest Coverage Ratio: 3.58 > 6 (EBITDA TTM 12.15b / Interest Expense TTM 1.19b) |
Altman Z'' 1.67
| A: -0.01 (Total Current Assets 8.81b - Total Current Liabilities 9.42b) / Total Assets 83.47b |
| B: 0.27 (Retained Earnings 22.20b / Total Assets 83.47b) |
| C: 0.05 (EBIT TTM 4.26b / Avg Total Assets 84.64b) |
| D: 0.48 (Book Value of Equity 22.64b / Total Liabilities 46.71b) |
| Altman-Z'' Score: 1.67 = BB |
Beneish M -3.08
| DSRI: 1.00 (Receivables 3.84b/3.92b, Revenue 26.77b/27.51b) |
| GMI: 1.05 (GM 33.57% / 35.27%) |
| AQI: 1.05 (AQ_t 0.07 / AQ_t-1 0.07) |
| SGI: 0.97 (Revenue 26.77b / 27.51b) |
| TATA: -0.11 (NI 2.07b - CFO 11.25b) / TA 83.47b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of OXY shares?
Over the past week, the price has changed by +2.03%, over one month by +10.95%, over three months by +15.58% and over the past year by +0.74%.
Is OXY a buy, sell or hold?
- StrongBuy: 4
- Buy: 4
- Hold: 17
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the OXY price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 48.9 | 5.7% |
| Analysts Target Price | 48.9 | 5.7% |
| ValueRay Target Price | 47.9 | 3.3% |
OXY Fundamental Data Overview February 03, 2026
P/E Forward = 16.1812
P/S = 1.6811
P/B = 1.5871
P/EG = 1.1574
Revenue TTM = 26.77b USD
EBIT TTM = 4.26b USD
EBITDA TTM = 12.15b USD
Long Term Debt = 20.21b USD (from longTermDebt, last quarter)
Short Term Debt = 2.03b USD (from shortTermDebt, last quarter)
Debt = 22.88b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.72b USD (from netDebt column, last quarter)
Enterprise Value = 65.44b USD (44.72b + Debt 22.88b - CCE 2.16b)
Interest Coverage Ratio = 3.58 (Ebit TTM 4.26b / Interest Expense TTM 1.19b)
EV/FCF = 17.22x (Enterprise Value 65.44b / FCF TTM 3.80b)
FCF Yield = 5.81% (FCF TTM 3.80b / Enterprise Value 65.44b)
FCF Margin = 14.19% (FCF TTM 3.80b / Revenue TTM 26.77b)
Net Margin = 7.72% (Net Income TTM 2.07b / Revenue TTM 26.77b)
Gross Margin = 33.57% ((Revenue TTM 26.77b - Cost of Revenue TTM 17.79b) / Revenue TTM)
Gross Margin QoQ = 32.62% (prev 30.19%)
Tobins Q-Ratio = 0.78 (Enterprise Value 65.44b / Total Assets 83.47b)
Interest Expense / Debt = 1.18% (Interest Expense 270.0m / Debt 22.88b)
Taxrate = 27.79% (324.0m / 1.17b)
NOPAT = 3.07b (EBIT 4.26b * (1 - 27.79%))
Current Ratio = 0.94 (Total Current Assets 8.81b / Total Current Liabilities 9.42b)
Debt / Equity = 0.63 (Debt 22.88b / totalStockholderEquity, last quarter 36.26b)
Debt / EBITDA = 1.71 (Net Debt 20.72b / EBITDA 12.15b)
Debt / FCF = 5.45 (Net Debt 20.72b / FCF TTM 3.80b)
Total Stockholder Equity = 35.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.44% (Net Income 2.07b / Total Assets 83.47b)
RoE = 5.87% (Net Income TTM 2.07b / Total Stockholder Equity 35.21b)
RoCE = 7.68% (EBIT 4.26b / Capital Employed (Equity 35.21b + L.T.Debt 20.21b))
RoIC = 6.07% (NOPAT 3.07b / Invested Capital 50.62b)
WACC = 6.55% (E(44.72b)/V(67.59b) * Re(9.46%) + D(22.88b)/V(67.59b) * Rd(1.18%) * (1-Tc(0.28)))
Discount Rate = 9.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 2.75%
[DCF Debug] Terminal Value 80.48% ; FCFF base≈4.14b ; Y1≈3.26b ; Y5≈2.14b
Fair Price DCF = 34.41 (EV 54.62b - Net Debt 20.72b = Equity 33.90b / Shares 985.2m; r=6.55% [WACC]; 5y FCF grow -25.35% → 2.90% )
EPS Correlation: -84.78 | EPS CAGR: -56.99% | SUE: -4.0 | # QB: 0
Revenue Correlation: -72.47 | Revenue CAGR: -4.24% | SUE: -0.55 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=-0.191 | Revisions Net=-3 | Analysts=15
EPS next Year (2026-12-31): EPS=1.18 | Chg30d=-0.436 | Revisions Net=-4 | Growth EPS=-46.3% | Growth Revenue=-16.1%